Skip to main content

Hologic Inc

HOLXDelisted Apr 7, 2026
Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
SEC CIK
0000859737

Hologic Inc was delisted on Apr 7, 2026; its insiders filed their last Form 4 on Apr 9, 2026; 710 institutions reported holding it in 13F filings for Q1 2026, worth $16.3B in total; Soros Fund Management was the only superinvestor holding it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 8, 2026, 11:44 AM ET

Income statement

Each column is one fiscal year, newest first.

Income statement of Hologic Inc, annual
Line itemFY2025!FY2024FY2023FY2022FY2021
Period endSep 27, 2025Sep 28, 2024Sep 30, 2023Sep 24, 2022Sep 25, 2021
Filing10-K10-K10-K10-K10-K
ReportedNov 3, 2025Nov 4, 2024Nov 9, 2023Oct 31, 2022Nov 1, 2021
Revenue$4.10B$4.03B$4.03B$4.86B$5.63B
Cost of revenue$1.60B––––
Gross profit$2.12B$2.23B$2.07B$3.00B$3.80B
Operating expenses$1.40B$1.35B$1.40B$1.36B$1.32B
Research and development$248.2M$272.8M$294.3M$283.4M$276.3M
Selling, general and administrative$449.3M$409.4M$392.4M$407.7M$433.2M
Operating income$714.3M$882.6M$668.4M$1.64B$2.48B
Interest expense–$122.1M$111.1M$95.1M$93.6M
Income tax$115.5M$75.6M$220.1M$286.2M$491.4M
Net income$565.7M$789.5M$456.0M$1.30B$1.87B
EPS, basic$2.50$3.35$1.85$5.18$7.28
EPS, diluted$2.49$3.32$1.83$5.13$7.21
Weighted shares, basic226.2M235.7M246.8M251.5M257.0M
Weighted shares, diluted227.6M237.6M248.8M253.8M259.7M
Margins and growth
Gross margin51.6%55.3%51.4%61.6%67.4%
Operating margin17.4%21.9%16.6%33.7%44.0%
Net margin13.8%19.6%11.3%26.8%33.2%
Revenue growth, year over year+1.7%0.0%−17.1%−13.7%+49.1%
Net income growth, year over year−28.3%+73.1%−65.0%−30.4%+67.8%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Hologic Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endSep 27, 2025Sep 28, 2024Sep 30, 2023Sep 24, 2022Sep 25, 2021
Filing10-K10-K10-K10-K10-K
ReportedNov 3, 2025Nov 4, 2024Nov 9, 2023Oct 31, 2022Nov 1, 2021
Cash and equivalents$1.96B$2.16B$2.72B$2.34B$1.17B
Short-term investments$243.2M$173.4M–––
Accounts receivable$600.8M$600.4M$625.6M$617.6M$942.7M
Inventory$679.4M$679.8M$617.6M$623.7M$501.2M
Total current assets$3.67B$3.82B$4.18B$3.86B$3.17B
Property, plant and equipment$559.6M$537.8M$517.0M$481.6M$564.7M
Goodwill$3.64B$3.44B$3.28B$3.24B$3.28B
Intangible assets$589.1M$844.6M$888.6M$1.28B$1.66B
Total assets$9.01B$9.16B$9.14B$9.07B$8.92B
Accounts payable$193.4M$203.8M$175.2M$197.7M$215.9M
Short-term debt$2.90M$37.5M$287.0M$15.0M$313.0M
Total current liabilities$977.2M$1.04B$1.21B$937.7M$1.33B
Long-term debt$2.50B$2.50B$2.53B$2.81B$2.71B
Shareholders' equity$5.05B$5.13B$5.02B$4.88B$4.22B

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Hologic Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endSep 27, 2025Sep 28, 2024Sep 30, 2023Sep 24, 2022Sep 25, 2021
Filing10-K10-K10-K10-K10-K
ReportedNov 3, 2025Nov 4, 2024Nov 9, 2023Oct 31, 2022Nov 1, 2021
Operating cash flow$1.06B$1.29B$1.05B$2.13B$2.33B
Capital expenditures$58.8M$72.4M$91.8M$70.6M$96.8M
Free cash flow$998.3M$1.21B$959.4M$2.06B$2.23B
Depreciation and amortization$299.8M$309.0M$323.4M$430.1M$406.9M
Stock-based compensation$84.3M$82.3M$79.6M$66.7M$65.0M
Share buybacks$752.9M$835.1M$474.8M$542.1M$409.8M
Investing cash flow-$482.7M-$781.0M-$152.1M-$206.3M-$1.33B
Financing cash flow-$777.2M-$1.11B-$483.2M-$756.0M-$529.8M
Net change in cash-$200.7M-$595.5M$416.2M$1.17B$469.3M
Ratio
Stock-based compensation, % of revenue2.1%2.0%2.0%1.4%1.2%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Hologic Inc by cover date
Cover dateShares outstandingChange in a yearFiling
Jan 23, 2026223.2M−0.5%SEC
Jan 16, 2026223.2M−0.5%SEC
Nov 13, 2025222.9M−1.8%SEC
Jul 25, 2025222.4M−4.2%SEC
Apr 25, 2025222.8M−4.5%SEC
Jan 31, 2025224.4M−4.4%SEC
Nov 21, 2024226.9M−5.4%SEC
Jul 25, 2024232.3M−5.2%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
  • A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.